Myasthenia Gravis Clinical Trials in Palo Alto, California

5 studies are recruiting for myasthenia gravis in Palo Alto, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases

   This study will have two Phases: Phase 1a and Phase 1b. The goals of this clinical study are to learn more about the study drug KITE-363, by evaluating its safety, tolerability and efficacy in participants with relapsed/refractory autoimmune neurologic diseases. The primary objectives of this study…

   Stage

   Phase 1

   Ages

   18 to 75

   Site

   Stanford Neuroscience Health Center, Palo Alto, California

   Locations

   8 in total

   Run by

   Kite, A Gilead Company

   See if you can join NCT07304154 on ClinicalTrials.gov

2. A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis

   The purpose of this study is to determine the effect of nipocalimab on total serum immunoglobulin G (IgG) in pediatric participants 2 to less than (<) 18 years of age (globally) and 8 to <18 years of age (for Unites Stated (US) sites only), the safety and tolerability of treatment with nipocalimab …

   Stage

   Phase 2

   Ages

   2 to 17

   Site

   Lucile Packard Children's Hospital Stanford, Palo Alto, California

   Locations

   19 in total

   Run by

   Janssen Research & Development, LLC

   See if you can join NCT05265273 on ClinicalTrials.gov

3. KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis

   A Study of the Anti-CD 19 Chimeric Antigen Receptor T Cell Therapy for Patients with Myasthenia Gravis

   Stage

   Phase 2

   Ages

   18 to 75

   Site

   Stanford University Medical Center, Palo Alto, California

   Locations

   22 in total

   Run by

   Kyverna Therapeutics

   See if you can join NCT06193889 on ClinicalTrials.gov

4. A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis

   The purpose of this study is to evaluate the efficacy and safety of nipocalimab compared to placebo in participants with generalized myasthenia gravis (gMG). The purpose of the subcutaneous substudy is to evaluate how well it works in the body (pharmacodynamic [PD]) when given as an injection under…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Stanford University, Palo Alto, California

   Locations

   112 in total

   Run by

   Janssen Research & Development, LLC

   See if you can join NCT04951622 on ClinicalTrials.gov

5. A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases

   A Phase 1 dose-escalation study designed to evaluate the safety, tolerability, and preliminary efficacy of anito-cel in subjects with generalized myasthenia gravis (GMG). Anitocabtagene autoleucel (anito-cel) is a BCMA-directed CAR-T cell therapy.

   Stage

   Phase 1

   Ages

   18 and older

   Site

   Stanford Hospital, Palo Alto, California

   Locations

   13 in total

   Run by

   Arcellx, Inc.

   See if you can join NCT06626919 on ClinicalTrials.gov